|
|
|
Volumn 57, Issue 3, 2002, Pages 519-544
|
|
Pediatric marketing exclusivity - As altered by the Best Pharmaceuticals for Children Act of 2002
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
GENERIC DRUG;
METFORMIN;
NEW DRUG;
DRUG APPROVAL;
DRUG INDICATION;
DRUG INDUSTRY;
DRUG INFORMATION;
DRUG LABELING;
DRUG LEGISLATION;
DRUG MARKETING;
DRUG RESEARCH;
DRUG SAFETY;
FOOD AND DRUG ADMINISTRATION;
HUMAN;
LAW ENFORCEMENT;
PATENT;
PEDIATRICS;
REVIEW;
CHILD;
CONTRACT SERVICES;
DRUGS, INVESTIGATIONAL;
ECONOMIC COMPETITION;
HUMANS;
LEGISLATION, DRUG;
MARKETING OF HEALTH SERVICES;
PEDIATRICS;
PRODUCT LABELING;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
|
EID: 0037001553
PISSN: 1064590X
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (5)
|
|
References (0)
|
